{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T05:10:52Z","timestamp":1779340252922,"version":"3.51.4"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Post-thrombotic syndrome (PTS) is a common long-term complication following deep vein thrombosis (DVT), leading to substantial morbidity and impaired quality of life. Elastic compression stockings (ECS) are widely used for PTS prevention; however, their effectiveness remains controversial, particularly across different severities of PTS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>A systematic review and meta-analysis of randomized controlled trials (RCTs) was conducted to evaluate the effectiveness of ECS in preventing PTS after DVT. Electronic databases were searched from inception to January 20, 2026. The primary outcomes were the overall incidence of PTS at final follow-up, as well as the incidence of mild-to-moderate and severe PTS. Secondary outcomes included recurrent DVT and all-cause mortality. Risk ratios (RRs) with 95% confidence intervals (CIs) were pooled using a random-effects model. The certainty of evidence was assessed using the GRADE approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Eight trials involving 1,775 patients were included. ECS were associated with a modest reduction in total PTS (RR 0.70; 95% CI 0.51\u20130.96; absolute reduction ~127 per 1,000), corresponding to an absolute reduction of approximately 142 cases per 1,000 patients. When stratified by severity, ECS reduced mild-to-moderate PTS (RR 0.69; 95% CI 0.50\u20130.93; absolute reduction ~129 per 1,000), whereas effects on severe PTS were uncertain (RR 0.56; 95% CI 0.22\u20131.43). No clear impact was observed on recurrent DVT (RR 0.90; 95% CI 0.73\u20131.11) or all-cause mortality (RR 0.98; 95% CI 0.68\u20131.40). Certainty of evidence was low for total and mild-to-moderate PTS and very low for severe PTS, recurrent DVT, and mortality. Heterogeneity in adherence, control group design, PTS definitions, and initial DVT management may have influenced outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Long-term ECS may modestly reduce mild-to-moderate PTS after DVT, but their effect on severe PTS, recurrent DVT, and mortality remains uncertain. ECS may improve symptoms, but their preventive effect is limited, and clinical decisions should consider patient-specific factors, adherence, and the multifactorial determinants of PTS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic review registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/www.crd.york.ac.uk\/PROSPERO\/view\/CRD420261386069<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1840243","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T04:39:35Z","timestamp":1779338375000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Effectiveness of long-term graduated compression stockings after deep vein thrombosis: a GRADE-based meta-analysis of randomized controlled trials"],"prefix":"10.3389","volume":"13","author":[{"given":"Yuanjie","family":"Duan","sequence":"first","affiliation":[{"name":"Hunan Key Laboratory of the Research and Development of Novel Pharmaceutical Preparations, School of Public Health, Changsha Medical University","place":["Changsha, China"]},{"name":"Hunan Provincial University Key Laboratory of the Fundamental and Clinical Research on Neurodegenerative Diseases, Changsha Medical University","place":["Changsha, China"]},{"name":"School of Public Health, Changsha Medical University","place":["Changsha, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Liu","sequence":"additional","affiliation":[{"name":"Hunan Key Laboratory of the Research and Development of Novel Pharmaceutical Preparations, School of Public Health, Changsha Medical University","place":["Changsha, China"]},{"name":"Hunan Provincial University Key Laboratory of the Fundamental and Clinical Research on Neurodegenerative Diseases, Changsha Medical University","place":["Changsha, China"]},{"name":"School of Public Health, Changsha Medical University","place":["Changsha, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiyu","family":"Lin","sequence":"additional","affiliation":[{"name":"Hunan Key Laboratory of the Research and Development of Novel Pharmaceutical Preparations, School of Public Health, Changsha Medical University","place":["Changsha, China"]},{"name":"Hunan Provincial University Key Laboratory of the Fundamental and Clinical Research on Neurodegenerative Diseases, Changsha Medical University","place":["Changsha, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Li","sequence":"additional","affiliation":[{"name":"Hunan Key Laboratory of the Research and Development of Novel Pharmaceutical Preparations, School of Public Health, Changsha Medical University","place":["Changsha, China"]},{"name":"Hunan Provincial University Key Laboratory of the Fundamental and Clinical Research on Neurodegenerative Diseases, Changsha Medical University","place":["Changsha, China"]},{"name":"School of Public Health, Changsha Medical University","place":["Changsha, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Luo","sequence":"additional","affiliation":[{"name":"Hunan Key Laboratory of the Research and Development of Novel Pharmaceutical Preparations, School of Public Health, Changsha Medical University","place":["Changsha, China"]},{"name":"Hunan Provincial University Key Laboratory of the Fundamental and Clinical Research on Neurodegenerative Diseases, Changsha Medical University","place":["Changsha, China"]},{"name":"School of Public Health, Changsha Medical University","place":["Changsha, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lemei","family":"Zhu","sequence":"additional","affiliation":[{"name":"Hunan Key Laboratory of the Research and Development of Novel Pharmaceutical Preparations, School of Public Health, Changsha Medical University","place":["Changsha, China"]},{"name":"Hunan Provincial University Key Laboratory of the Fundamental and Clinical Research on Neurodegenerative Diseases, Changsha Medical University","place":["Changsha, China"]},{"name":"School of Public Health, Changsha Medical University","place":["Changsha, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/nrcardio.2015.83","article-title":"Epidemiology of venous thromboembolism","volume":"12","author":"Heit","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1001\/archinte.164.1.17","article-title":"Relationship between deep venous thrombosis and the postthrombotic syndrome","volume":"164","author":"Kahn","year":"2004","journal-title":"Arch Intern Med"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1182\/asheducation-2016.1.413","article-title":"The post-thrombotic syndrome","volume":"2016","author":"Kahn","year":"2016","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/jth.13569","article-title":"The postthrombotic syndrome: current evidence and future challenges","volume":"15","author":"Rabinovich","year":"2017","journal-title":"J Thromb Haemost"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1111\/j.1538-7836.2009.03294.x","article-title":"Definition of post-thrombotic syndrome of the leg for use in clinical investigations: a recommendation for standardization","volume":"7","author":"Kahn","year":"2009","journal-title":"J Thromb Haemost"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.chest.2015.11.026","article-title":"Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report","volume":"149","author":"Kearon","year":"2016","journal-title":"Chest"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"181","DOI":"10.23736\/s0392-9590.18.03999-8","article-title":"Management of chronic venous disorders of the lower limbs. Guidelines according to scientific evidence. Part I","volume":"37","author":"Nicolaides","year":"2018","journal-title":"Int Angiol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"112178","DOI":"10.1016\/j.intimp.2024.112178","article-title":"Clinical features, treatment, and outcomes of patients with carfilzomib induced thrombotic microangiopathy","volume":"134","author":"Fang","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"CD004174","DOI":"10.1002\/14651858.CD004174.pub3","article-title":"Compression therapy for prevention of post-thrombotic syndrome","volume":"2017","author":"Appelen","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/s0140-6736(96)12215-7","article-title":"Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis","volume":"349","author":"Brandjes","year":"1997","journal-title":"Lancet"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"833329","DOI":"10.3389\/fcvm.2022.833329","article-title":"Direct oral anticoagulants vs. vitamin K antagonists in atrial fibrillation patients at risk of falling: a meta-analysis","volume":"9","author":"Gao","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/s0140-6736(13)61902-9","article-title":"Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial","volume":"383","author":"Kahn","year":"2014","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"113092","DOI":"10.1016\/j.diabres.2026.113092","article-title":"The burden and mortality impact of cardiovascular disease-metabolic dysfunction-associated steatotic liver disease comorbidity","volume":"232","author":"Tan","year":"2026","journal-title":"Diabetes Res Clin Pract"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.bjps.2023.10.050","article-title":"Variations in deep iliac circumflex artery perforator chimeric flap design for single-stage customized-reconstruction of composite bone and soft-tissue defect","volume":"87","author":"Zhang","year":"2023","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"14791641231173627","DOI":"10.1177\/14791641231173627","article-title":"Comparative study of microvascular structural changes in the gestational diabetic placenta","volume":"20","author":"Liang","year":"2023","journal-title":"Diab Vasc Dis Res"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/jth.13228","article-title":"Eliciting patients\u2019 preferences for elastic compression stocking therapy after deep vein thrombosis: potential for improving compliance","volume":"14","author":"Bouman","year":"2016","journal-title":"J Thromb Haemost"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s10637-024-01472-w","article-title":"Clinical characteristics, treatment, and outcomes of nivolumab induced immune thrombocytopenia","volume":"42","author":"Peng","year":"2024","journal-title":"Investig New Drugs"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"105906","DOI":"10.1016\/j.ijsu.2021.105906","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"88","author":"Page","year":"2021","journal-title":"Int J Surg"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1002\/sim.791","article-title":"On tests of the overall treatment effect in meta-analysis with normally distributed responses","volume":"20","author":"Hartung","year":"2001","journal-title":"Stat Med"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1002\/sim.1262","article-title":"A simple confidence interval for meta-analysis","volume":"21","author":"Sidik","year":"2002","journal-title":"Stat Med"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"e081903","DOI":"10.1136\/bmj-2024-081903","article-title":"Core GRADE 1: overview of the Core GRADE approach","volume":"389","author":"Guyatt","year":"2025","journal-title":"BMJ"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"e081904","DOI":"10.1136\/bmj-2024-081904","article-title":"Core GRADE 2: choosing the target of certainty rating and assessing imprecision","volume":"389","author":"Guyatt","year":"2025","journal-title":"BMJ"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"e081905","DOI":"10.1136\/bmj-2024-081905","article-title":"Core GRADE 3: rating certainty of evidence-assessing inconsistency","volume":"389","author":"Guyatt","year":"2025","journal-title":"BMJ"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"e083864","DOI":"10.1136\/bmj-2024-083864","article-title":"Core GRADE 4: rating certainty of evidence-risk of bias, publication bias, and reasons for rating up certainty","volume":"389","author":"Guyatt","year":"2025","journal-title":"BMJ"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"e083865","DOI":"10.1136\/bmj-2024-083865","article-title":"Core GRADE 5: rating certainty of evidence-assessing indirectness","volume":"389","author":"Guyatt","year":"2025","journal-title":"BMJ"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"e083866","DOI":"10.1136\/bmj-2024-083866","article-title":"Core GRADE 6: presenting the evidence in summary of findings tables","volume":"389","author":"Guyatt","year":"2025","journal-title":"BMJ"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"e083867","DOI":"10.1136\/bmj-2024-083867","article-title":"Core GRADE 7: principles for moving from evidence to recommendations and decisions","volume":"389","author":"Guyatt","year":"2025","journal-title":"BMJ"},{"key":"ref30","volume-title":"Cystic Fibrosis: Diagnosis and Management","year":"2017"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2024-328166","article-title":"Adrenal insufficiency: identification and management (NICE guideline NG243)","author":"Bimb","year":"2026","journal-title":"Arch Dis Child Educ Pract Ed"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"e076226","DOI":"10.1136\/bmj-2023-076226","article-title":"Management of chronic pain secondary to temporomandibular disorders: a systematic review and network meta-analysis of randomised trials","volume":"383","author":"Yao","year":"2023","journal-title":"BMJ"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.jvs.2008.01.008","article-title":"Effect of prolonged treatment with compression stockings to prevent post-thrombotic sequelae: a randomized controlled trial","volume":"47","author":"Aschwanden","year":"2008","journal-title":"J Vasc Surg"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1001\/archinte.161.17.2105","article-title":"Prevention and treatment of postphlebitic syndrome: results of a 3-part study","volume":"161","author":"Ginsberg","year":"2001","journal-title":"Arch Intern Med"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1177\/0268355514544781","article-title":"Impact of graduated compression stockings on the prevention of post-thrombotic syndrome - results of a randomized controlled trial","volume":"30","author":"Jayaraj","year":"2015","journal-title":"Phlebology"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"249","DOI":"10.7326\/0003-4819-141-4-200408170-00004","article-title":"Below-knee elastic compression stockings to prevent the post-thrombotic syndrome: a randomized, controlled trial","volume":"141","author":"Prandoni","year":"2004","journal-title":"Ann Intern Med"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"znaf018","DOI":"10.1093\/bjs\/znaf018","article-title":"Compression hosiery to avoid post-thrombotic syndrome: CHAPS randomized clinical trial","volume":"112","author":"Thapar","year":"2025","journal-title":"Br J Surg"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.jvsv.2021.06.023","article-title":"Elastic compression stockings to prevent post-thrombotic syndrome in proximal deep venous thrombosis patients without thrombus removal","volume":"10","author":"Yang","year":"2022","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"4693","DOI":"10.1182\/bloodadvances.2020001830","article-title":"American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism","volume":"4","author":"Ortel","year":"2020","journal-title":"Blood Adv"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"e545","DOI":"10.1016\/j.chest.2021.07.055","article-title":"Antithrombotic therapy for VTE disease: second update of the CHEST guideline and expert panel report","volume":"160","author":"Stevens","year":"2021","journal-title":"Chest"},{"key":"ref41","first-page":"323","volume-title":"StatPearls","author":"Calderon Martinez","year":"2026"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"923","DOI":"10.3390\/jcm9040923","article-title":"Prevention and management of the post-thrombotic syndrome","volume":"9","author":"Makedonov","year":"2020","journal-title":"J Clin Med"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1097\/MOH.0b013e32830abde2","article-title":"Long-term prognosis after deep venous thrombosis","volume":"15","author":"Shbaklo","year":"2008","journal-title":"Curr Opin Hematol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"e71656","DOI":"10.1002\/hsr2.71656","article-title":"Post-thrombotic syndrome: pathophysiology, clinical implications, and advances in management","volume":"8","author":"Htun","year":"2025","journal-title":"Health Sci Rep"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.thromres.2017.07.008","article-title":"Prevention and treatment of the post-thrombotic syndrome","volume":"164","author":"Pikovsky","year":"2018","journal-title":"Thromb Res"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1840243\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T04:39:51Z","timestamp":1779338391000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1840243\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":45,"alternative-id":["10.3389\/fmed.2026.1840243"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1840243","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]},"article-number":"1840243"}}